ATA Guidelines: Do Patients with Stage I Thyroid Cancer Benefit From ¹³¹I?

This publication has 9 references indexed in Scilit:

• Guidance for Guidelines
  New England Journal of Medicine, 2007
• Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
  Thyroid®, 2006
• Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma
  Journal of Surgical Oncology, 2006
• Second Primary Cancers in Thyroid Cancer Patients: A Multinational Record Linkage Study
  Journal of Clinical Endocrinology & Metabolism, 2006
• Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
  Thyroid®, 2006
• Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years
  Clinical Endocrinology, 2005
• A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer
  Journal of Clinical Endocrinology & Metabolism, 2004
• Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study
  European Journal of Nuclear Medicine and Molecular Imaging, 2002
• Leukaemias and cancers following iodine-131 administration for thyroid cancer
  British Journal of Cancer, 1997